Skip to content

Clinical trials

Phase 1 Sarcoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 1 Country / region: China Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20192
20203
20212
20222
20236
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10
Recruiting5
Terminated3
Active, not recruiting1
Completed1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai Yunying Medical Technology5
Shanghai PerHum Therapeutics Co., Ltd.3
Sun Yat-sen University3
Base Therapeutics (Shanghai) Co., Ltd.1
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1
FindCure Biosciences (ZhongShan) Co., Ltd.1
GONGCHU Biotechnology Co., Ltd1
Guangzhou FineImmune Biotechnology Co., LTD.1
HRYZ Biotech Co.1
Hebei Senlang Biotechnology Inc., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma21
Breast Neoplasms6
Lung Neoplasms5
Osteosarcoma5
Stomach Neoplasms5
Pancreatic Neoplasms4
Bone Neoplasms3
Head and Neck Neoplasms3
Ovarian Neoplasms3
Carcinoma2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.